3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
15
Endometrial Neoplasms
11
Carcinoma, Non-Small-Cell Lung
10
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Ovarian Neoplasms
4
Head and Neck Neoplasms
4
Pancreatic Neoplasms
3
Melanoma
3
Colonic Neoplasms
3
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Osteosarcoma
2
Locally Advanced Rectal Cancer (LARC)
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Neuroendocrine
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Interventions
pembrolizumab
4
aldesleukin
3
Cisplatin
3
lenvatinib
2
Surveys and Questionnaires
2
Specimen Handling
2
Paclitaxel
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
fludarabine phosphate
1
fludarabine
1
entinostat
1
dostarlimab
1
cemiplimab
1
bintrafusp alfa protein, human
1
belzutifan
1
atezolizumab
1
Therapeutic Touch
1
Taxes
1
Standard of Care
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy
1
Radiation
1
Prochlorperazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
dostarlimab
×
1 year
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled